A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy
Clinical trial NCT01058512 · COMPLETED
Trial details
- NCT number
- NCT01058512
- Sponsor
- Cellectar Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.